This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Laboratoire Francais Du Fractionnement Et Des Biotechnologies. Active years: 2017-2020.
Company Filing History:
Years Active: 2017-2020
Title: Innovations of Stephane Boyer in Albumin Purification
Introduction
Stephane Boyer is a notable inventor based in Pecqueuse, France. He has made significant contributions to the field of biotechnologies, particularly in the purification of albumin. With a total of 2 patents to his name, Boyer's work focuses on enhancing therapeutic applications through innovative methods.
Latest Patents
Boyer's latest patents include an albumin-purification method that incorporates a nanofiltration step. This method involves subjecting an aqueous albumin solution, with a concentration ranging from 15 g/l to 80 g/l and a pH of not less than 7, to nanofiltration within a temperature range of 15°C to 55°C. The invention also encompasses a virally-safe aqueous albumin solution, which is produced using this method. This solution ensures that the sites for the transport and binding of active therapeutic ingredients remain available. Additionally, an albumin composition for therapeutic use is derived from adapting the albumin solution intended for clinical applications.
Career Highlights
Stephane Boyer is associated with Laboratoire Français du Fractionnement et des Biotechnologies, where he continues to advance his research and innovations. His work has been pivotal in developing safer and more effective therapeutic solutions.
Collaborations
Boyer collaborates with esteemed colleagues such as Paul Boulange and Roland Schmitthaeusler, contributing to a dynamic research environment that fosters innovation.
Conclusion
Stephane Boyer's contributions to albumin purification represent a significant advancement in biotechnological applications. His innovative methods and collaborative efforts continue to enhance therapeutic solutions in the medical field.